Design, Synthesis and In Vitro Study of 5,6‐Diaryl‐1,2,4‐triazine‐3‐ylthioacetate Derivatives as COX‐2 and β‐Amyloid Aggregation Inhibitors
By Sakineh Dadashpour, Tuba Tuylu Kucukkilinc, Oya Unsal Tan, Keriman Ozadali, H. Irannejad, S. Emami. 2015
30 citations recorded by the source corpus.
Subfields: Computational Theory and Mathematics, Organic Chemistry, Pharmacology, Computational Chemistry & Drug Discovery
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Computational Theory and Mathematics
- Glaucius Oliva
- L. Ferreira
- Ricardo N Dos Santos
- Maria Batool
- Adriano Defini Andricopulo
- Sangdun Choi
- Bilal Ahmad
- Luca Pinzi
In Organic Chemistry
- Glaucius Oliva
- Maria Batool
- Adriano Defini Andricopulo
- L. Ferreira
- Sangdun Choi
- Ricardo N Dos Santos
- Bilal Ahmad
- Luca Pinzi
In Pharmacology
In Computational Chemistry & Drug Discovery
- Glaucius Oliva
- Maria Batool
- Adriano Defini Andricopulo
- L. Ferreira
- Sangdun Choi
- Ricardo N Dos Santos
- Bilal Ahmad
- Giulio Rastelli
Citations in the corpus
- Molecular Docking and Structure-Based Drug Design Strategies (2015, background): “Recently, a series of selective COX-2 inhibitors acting as β -amyloid aggregation blockers was discovered via molecular docking [224].”
- A Structure-Based Drug Discovery Paradigm (2019, background): “Flurbiprofen Cyclooxygenase-2 Rheumatoid arthritis, Osteoarthritis Molecular docking [25, 26]”